USANA Health Sciences Inc (USNA)
Working capital turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 923,232 | 929,999 | 950,124 | 976,483 | 1,001,860 | 1,041,382 | 1,082,496 | 1,155,009 | 1,190,168 | 1,235,586 | 1,258,823 | 1,180,028 | 1,137,751 | 1,095,421 | 1,057,506 | 1,054,531 | 1,060,902 | 1,088,627 | 1,124,796 | 1,170,240 |
| Total current assets | US$ in thousands | 417,746 | 390,460 | 387,646 | 395,878 | 384,382 | 341,154 | 342,004 | 363,785 | 365,117 | 368,425 | 381,506 | 373,180 | 425,286 | 386,032 | 324,949 | 286,763 | 329,279 | 282,978 | 348,783 | 370,179 |
| Total current liabilities | US$ in thousands | 118,845 | 112,559 | 113,839 | 130,222 | 143,833 | 125,846 | 133,594 | 157,967 | 160,790 | 157,964 | 153,000 | 151,452 | 168,073 | 160,863 | 139,717 | 124,504 | 136,098 | 129,646 | 128,759 | 129,992 |
| Working capital turnover | 3.09 | 3.35 | 3.47 | 3.68 | 4.16 | 4.84 | 5.19 | 5.61 | 5.82 | 5.87 | 5.51 | 5.32 | 4.42 | 4.86 | 5.71 | 6.50 | 5.49 | 7.10 | 5.11 | 4.87 |
December 31, 2023 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $923,232K ÷ ($417,746K – $118,845K)
= 3.09
USANA Health Sciences Inc's working capital turnover has shown fluctuations over the past few quarters. The working capital turnover ratio measures how efficiently a company is using its working capital to generate sales revenue. A higher ratio indicates that the company is effectively utilizing its working capital to generate sales.
The working capital turnover for USANA Health Sciences Inc has generally been above 3, indicating that the company is efficiently utilizing its working capital. The trend shows that from December 2019 to March 2020, the ratio increased steadily, reaching a peak of 6.50 in March 2020. However, there was a slight decrease in the ratio in the following quarters.
From September 2020 to June 2021, the ratio fluctuated between 4.42 and 5.87, showing a less consistent trend. It peaked at 5.87 in September 2021 but decreased slightly in the following quarters.
In the most recent quarters, the working capital turnover ratio has ranged from 3.09 to 3.68, indicating a decrease compared to previous periods. The company may need to focus on optimizing its working capital management to improve efficiency in generating sales revenue. Overall, the analysis suggests that USANA Health Sciences Inc has shown variations in its working capital turnover performance, which may require further attention to maintain and improve efficiency in utilizing working capital.